Targeting immune activation in the prevention of pre-term labor

US Obstetrics and Gynecology

Volumn 6, Issue 2, 2011, Pages 103-109

  Sykes, Lynne ^a   Macintyre, David A ^a   Teoh, Tiong Ghee ^b   Bennett, Philip R ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b ST MARY S HOSPITAL   (United Kingdom)

Author keywords

Cytokines; Immune activation; Inflammation; Nuclear factor kappa B; Pre term labor

Indexed keywords

EID: 84860319168     PISSN: 17546168     EISSN: 17546176     Source Type: Journal    
DOI: None     Document Type: Article

References (114)

1. Tucker J, McGuire W, Epidemiology of preterm birth, BMJ, 2004;329:675-8
2. Challis JR, Lye SJ, Gibb W, et al., Understanding preterm labor, Ann N Y Acad Sci, 2001;943:225-34.
3. Mangham LJ, Petrou S, Doyle LW, et al., The cost of preterm birth throughout childhood in England and Wales, Pediatrics, 2009;123:e312-27.
4. Goldenberg RL, Hauth JC, Andrews WW, Intrauterine infection and preterm delivery, N Engl J Med, 2000;342:1500-7
5. Draper ES, Manktelow B, Field DJ, James D, Prediction of survival for preterm births by weight and gestational age: retrospective population based study, BMJ, 1999;319:1093-7
6. Hagberg H, Wennerholm UB, Savman K, Sequelae of chorioamnionitis, Curr Opin Infect Dis, 2002;15:301-6
7. Hagberg B, Hagberg G, Beckung E, Uvebrant P, Changing panorama of cerebral palsy in Sweden. VIII. Prevalence and origin in the birth year period 1991-94, Acta Paediatr, 2001;90:271-7.
8. Watterberg KL, Demers LM, Scott SM, Murphy S, Chorioamnionitis and early lung inflammation in infants in whom bronchopulmonary dysplasia develops, Pediatrics, 1996;97:210-5
9. Wu YW, Colford JM Jr, Chorioamnionitis as a risk factor for cerebral palsy: a meta-analysis, JAMA, 2000;284:1417-24
10. Friese K, The role of infection in preterm labour, BJOG, 2003;110(Suppl. 20):52-4.
11. Gotsch F, Romero R, Kusanovic JP, et al., The fetal inflammatory response syndrome, Clin Obstet Gynecol, 2007;50:652-83.
12. Gomez R, Romero R, Ghezzi F, et al., The fetal inflammatory response syndrome, Am J Obstet Gynecol, 1998;179:194-202.
13. Yoon BH, Romero R, Shim JY, et al., C-reactive protein in umbilical cord blood: a simple and widely available clinical method to assess the risk of amniotic fluid infection and funisitis, J Matern Fetal Neonatal Med, 2003;14:85-90.
14. Sampson JE, Theve RP, Blatman RN, et al., Fetal origin of amniotic fluid polymorphonuclear leukocytes, Am J Obstet Gynecol, 1997;176:77-81.
15. Yoneyama Y, Suzuki S, Sawa R, et al., Changes in the proportion of T helper 1 and T helper 2 cells in cord blood after premature rupture of membranes, Arch Gynecol Obstet, 2003;267:217-20.
16. Yoon BH, Jun JK, Romero R, et al., Amniotic fluid inflammatory cytokines (interleukin-6, interleukin-1beta, and tumor necrosis factor-alpha), neonatal brain white matter lesions, and cerebral palsy, Am J Obstet Gynecol, 1997;177:19-26.
17. Duggan PJ, Maalouf EF, Watts TL, et al., Intrauterine T-cell activation and increased proinflammatory cytokine concentrations in preterm infants with cerebral lesions, Lancet, 2001;358:1699-700.
18. Yoon BH, Romero R, Park JS, et al., Fetal exposure to an intraamniotic inflammation and the development of cerebral palsy at the age of three years, Am J Obstet Gynecol, 2000;182:675-81.
19. Yuan TM, Sun Y, Zhan CY, Yu HM, Intrauterine infection/inflammation and perinatal brain damage: role of glial cells and Toll-like receptor signaling, J Neuroimmunol, 2010;229:16-25
20. Medawar PB, Biological problems of skin surgery, J Int Chir, 1953;13:385-91
21. Romero R, Espinoza J, Goncalves LF, et al., The role of inflammation and infection in preterm birth, Semin Reprod Med, 2007;25:21-39.
22. Blank V, Hirsch E, Challis JR, et al., Cytokine signaling, inflammation, innate immunity and preterm labour - a workshop report, Placenta, 2008;29(Suppl. A):S102-4.
23. Matzinger P, The danger model: a renewed sense of self, Science, 2002;296:301-5
24. Akira S, Takeda K, Toll-like receptor signalling, Nat Rev Immunol, 2004;4:499-511
25. Takeuchi O, Hoshino K, Kawai T, et al., Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components, Immunity, 1999;11:443-51.
26. Koga K, Mor G, Toll-like receptors at the maternal-fetal interface in normal pregnancy and pregnancy disorders, Am J Reprod Immunol, 2010;63:587-600
27. Kim YM, Romero R, Chaiworapongsa T, et al., Toll-like receptor-2 and -4 in the chorioamniotic membranes in spontaneous labor at term and in preterm parturition that are associated with chorioamnionitis, Am J Obstet Gynecol, 2004;191:1346-55.
28. Youssef RE, Ledingham MA, Bollapragada SS, et al., The role of toll-like receptors (TLR-2 and -4) and triggering receptor expressed on myeloid cells 1 (TREM-1) in human term and preterm labor, Reprod Sci, 2009;16:843-56.
29. Akira S, Toll-like receptor signaling, J Biol Chem, 2003;278:38105-8
30. Aagaard-Tillery KM, Silver R, Dalton J, Immunology of normal pregnancy, Semin Fetal Neonatal Med, 2006;11:279-95
31. Akira S, Takeda K, Kaisho T, Toll-like receptors: critical proteins linking innate and acquired immunity, Nat Immunol, 2001;2:675-80
32. Challis JR, Lockwood CJ, Myatt L, et al., Inflammation and pregnancy, Reprod Sci, 2009;16:206-15.
33. Luppi P, How immune mechanisms are affected by pregnancy, Vaccine, 2003;21:3352-7
34. Raghupathy R, Th1-type immunity is incompatible with successful pregnancy, Immunol Today, 1997;18:478-82
35. Poole JA, Claman HN, Immunology of pregnancy. Implications for the mother, Clin Rev Allergy Immunol, 2004;26:161-70.
36. Romero R, Manogue KR, Mitchell MD, et al., Infection and labor. IV. Cachectin-tumor necrosis factor in the amniotic fluid of women with intraamniotic infection and preterm labor, Am J Obstet Gynecol, 1989;161:336-41.
37. Sadowsky DW, Adams KM, Gravett MG, et al., Preterm labor is induced by intraamniotic infusions of interleukin-1beta and tumor necrosis factor-alpha but not by interleukin-6 or interleukin-8 in a nonhuman primate model, Am J Obstet Gynecol, 2006;195:1578-89.
38. Tranchot-Diallo J, Gras G, Parnet-Mathieu F, et al., Modulations of cytokine expression in pregnant women, Am J Reprod Immunol, 1997;37:215-26.
39. Marzi M, Vigano A, Trabattoni D, et al., Characterization of type 1 and type 2 cytokine production profile in physiologic and pathologic human pregnancy, Clin Exp Immunol, 1996;106:127-33.
40. McCracken SA, Gallery E, Morris JM, Pregnancy-specific downregulation of NF-kappa B expression in T cells in humans is essential for the maintenance of the cytokine profile required for pregnancy success, J Immunol, 2004;172:4583-91
41. Piccinni MP, Beloni L, Livi C, et al., Defective production of both leukemia inhibitory factor and type 2 T-helper cytokines by decidual T cells in unexplained recurrent abortions, Nat Med, 1998;4:1020-4.
42. Chaouat G, Cayol V, Mairovitz V, Dubanchet S, Localization of the Th2 cytokines IL-3, IL-4, IL-10 at the fetomaternal interface during human and murine pregnancy and lack of requirement for Fas/Fas ligand interaction for a successful allogeneic pregnancy, Am J Reprod Immunol, 1999;42:1-13
43. Fortunato SJ, Menon R, Lombardi SJ, Interleukin-10 and transforming growth factor-beta inhibit amniochorion tumor necrosis factor-alpha production by contrasting mechanisms of action: therapeutic implications in prematurity, Am J Obstet Gynecol, 1997;177:803-9
44. Goodwin VJ, Sato TA, Mitchell MD, Keelan JA, Anti-inflammatory effects of interleukin-4, interleukin-10, and transforming growth factor-beta on human placental cells in vitro, Am J Reprod Immunol, 1998;40:319-25
45. Lappas M, Rice GE, Transcriptional regulation of the processes of human labour and delivery, Placenta, 2009;30(Suppl. A):S90-5.
46. Romero R, Espinoza J, Goncalves LF, K, et al., Inflammation in preterm and term labour and delivery, Semin Fetal Neonatal Med, 2006;11:317-26.
47. Casey ML, MacDonald PC, Biomolecular processes in the initiation of parturition: decidual activation, Clin Obstet Gynecol, 1988;31:533-52
48. Osman I, Young A, Ledingham MA, et al., Leukocyte density and pro-inflammatory cytokine expression in human fetal membranes, decidua, cervix and myometrium before and during labour at term, Mol Hum Reprod, 2003;9:41-5.
49. Lee Y, Allport V, Sykes A, et al., The effects of labour and of interleukin 1 beta upon the expression of nuclear factor kappa Brelated proteins in human amnion, Mol Hum Reprod, 2003;9:213-8.
50. Thomson AJ, Telfer JF, Young A, et al., Leukocytes infiltrate the myometrium during human parturition: further evidence that labour is an inflammatory process, Hum Reprod, 1999;14:229-36.
51. Leppert PC, Anatomy and physiology of cervical ripening, Clin Obstet Gynecol, 1995;38:267-79
52. Terzidou V, Preterm labour. Biochemical and endocrinological preparation for parturition, Best Pract Res Clin Obstet Gynaecol, 2007;21:729-56.
53. Young A, Thomson AJ, Ledingham M, et al., Immunolocalization of proinflammatory cytokines in myometrium, cervix, and fetal membranes during human parturition at term, Biol Reprod, 2002;66:445-9.
54. Bisits AM, Smith R, Mesiano S, et al., Inflammatory aetiology of human myometrial activation tested using directed graphs, PLoS Comput Biol, 2005;1:132-6.
55. Lappas M, Rice GE, The role and regulation of the nuclear factor kappa B signalling pathway in human labour, Placenta, 2007;28:543-56
56. Lindstrom TM, Bennett PR, The role of nuclear factor kappa B in human labour, Reproduction, 2005;130:569-81
57. Chapman NR, Europe-Finner GN, Robson SC, Expression and deoxyribonucleic acid-binding activity of the nuclear factor kappaB family in the human myometrium during pregnancy and labor, J Clin Endocrinol Metab, 2004;89:5683-93
58. Slater DM, Dennes WJ, Campa JS, et al., Expression of cyclooxygenase types-1 and -2 in human myometrium throughout pregnancy, Mol Hum Reprod, 1999;5:880-4.
59. Choi SJ, Oh S, Kim JH, Roh CR, Changes of nuclear factor kappa B (NF-kappaB), cyclooxygenase-2 (COX-2) and matrix metalloproteinase-9 (MMP-9) in human myometrium before and during term labor, Eur J Obstet Gynecol Reprod Biol, 2007;132:182-8
60. Lindstrom TM, Bennett PR, 15-Deoxy-{delta}12,14-prostaglandin j2 inhibits interleukin-1{beta}-induced nuclear factor-{kappa}b in human amnion and myometrial cells: mechanisms and implications, J Clin Endocrinol Metab, 2005;90:3534-43
61. Romero R, Parvizi ST, Oyarzun E, et al., Amniotic fluid interleukin-1 in spontaneous labor at term, J Reprod Med, 1990;35:235-8.
62. Elliott CL, Slater DM, Dennes W, et al., Interleukin 8 expression in human myometrium: changes in relation to labor onset and with gestational age, Am J Reprod Immunol, 2000;43:272-7.
63. Helmer H, Tretzmuller U, Brunbauer M, et al., Production of oxytocin receptor and cytokines in primary uterine smooth muscle cells cultivated under inflammatory conditions, J Soc Gynecol Investig, 2002;9:15-21.
64. Bollapragada S, Youssef R, Jordan F, et al., Term labor is associated with a core inflammatory response in human fetal membranes, myometrium, and cervix, Am J Obstet Gynecol, 2009;200:104.e1-11.
65. Khanjani S, Kandola MK, Lindstrom TM, et al., NF-kappaB regulates a cassette of immune/inflammatory genes in human pregnant myometrium at term, J Cell Mol Med, 2011;15:809-24.
66. Chan EC, Fraser S, Yin S, et al., Human myometrial genes are differentially expressed in labor: a suppression subtractive hybridization study, J Clin Endocrinol Metab, 2002;87:2435-41.
67. Condon JC, Jeyasuria P, Faust JM, Mendelson CR, Surfactant protein secreted by the maturing mouse fetal lung acts as a hormone that signals the initiation of parturition, Proc Natl Acad Sci U S A, 2004;101:4978-83
68. Gotsch F, Romero R, Erez O, et al., The preterm parturition syndrome and its implications for understanding the biology, risk assessment, diagnosis, treatment and prevention of preterm birth, J Matern Fetal Neonatal Med, 2009;22(Suppl. 2):5-23.
69. Challis JRG, Mechanism of parturition and preterm labor, Obstet Gynecol Surv, 2000;55:650-60
70. Goldenberg RL, Andrews WW, Hauth JC, Choriodecidual infection and preterm birth, Nutr Rev, 2002;60:S19-25
71. Romero R, Emamian M, Quintero R, et al., The value and limitations of the Gram stain examination in the diagnosis of intraamniotic infection, Am J Obstet Gynecol, 1988;159:114-9.
72. Hirsch E, Wang H, The molecular pathophysiology of bacterially induced preterm labor: insights from the murine model, J Soc Gynecol Investig, 2005;12:145-55
73. Romero R, Gomez R, Chaiworapongsa T, et al., The role of infection in preterm labour and delivery, Paediatr Perinat Epidemiol, 2001;15(Suppl. 2):41-56.
74. Romero R, Mazor M, Infection and preterm labor, Clin Obstet Gynecol, 1988;31:553-84
75. Hunt JS, Cytokine networks in the uteroplacental unit: macrophages as pivotal regulatory cells, J Reprod Immunol, 1989;16:1-17
76. Mitchell MD, Edwin S, Romero RJ, Prostaglandin biosynthesis by human decidual cells: effects of inflammatory mediators, Prostaglandins Leukot Essent Fatty Acids, 1990;41:35-8
77. Romero R, Durum S, Dinarello CA, et al., Interleukin-1 stimulates prostaglandin biosynthesis by human amnion, Prostaglandins, 1989;37:13-22.
78. Christiaens I, Zaragoza DB, Guilbert L, et al., Inflammatory processes in preterm and term parturition, J Reprod Immunol, 2008;79:50-7.
79. Elliott CL, Loudon JA, Brown N, et al., IL-1beta and IL-8 in human fetal membranes: changes with gestational age, labor, and culture conditions, Am J Reprod Immunol, 2001;46:260-7.
80. Haddad R, Tromp G, Kuivaniemi H, et al., Human spontaneous labor without histologic chorioamnionitis is characterized by an acute inflammation gene expression signature, Am J Obstet Gynecol, 2006;195:394.e1-24.
81. Horton JS, Yamamoto SY, Bryant-Greenwood GD, Relaxin modulates proinflammatory cytokine secretion from human decidual macrophages, Biol Reprod, 2011;85:788-97
82. Meis PJ, Klebanoff M, Thom E, et al., Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate, N Engl J Med, 2003;348:2379-85.
83. Da Fonseca EB, Bittar RE, Carvalho MH, Zugaib M, Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomized placebo-controlled double-blind study, Am J Obstet Gynecol, 2003;188:419-24
84. Fonseca EB, Celik E, Parra M, et al., Progesterone and the risk of preterm birth among women with a short cervix, N Engl J Med, 2007;357:462-9.
85. Hassan SS, Romero R, Vidyadhari D, et al., Vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix: a multicenter, randomized, doubleblind, placebo-controlled trial, Ultrasound Obstet Gynecol, 2011;38:18-31.
86. Kilarski WM, Hongpaisan J, Semik D, Roomans GM, Effect of progesterone and oestradiol on expression of connexin43 in cultured human myometrium cells, Folia Histochem Cytobiol, 2000;38:3-9
87. Shimonovitz S, Hurwitz A, Hochner-Celnikier D, et al., Expression of gelatinase B by trophoblast cells: downregulation by progesterone, Am J Obstet Gynecol, 1998;178:457-61.
88. Loudon JA, Elliott CL, Hills F, Bennett PR, Progesterone represses interleukin-8 and cyclo-oxygenase-2 in human lower segment fibroblast cells and amnion epithelial cells, Biol Reprod, 2003;69:331-7
89. Fomin VP, Cox BE, Word RA, Effect of progesterone on intracellular Ca2+ homeostasis in human myometrial smooth muscle cells, Am J Physiol, 1999;276:C379-85
90. Kofinas AD, Rose JC, Koritnik DR, Meis PJ, Progesterone and estradiol concentrations in nonpregnant and pregnant human myometrium. Effect of progesterone and estradiol on cyclic adenosine monophosphate-phosphodiesterase activity, J Reprod Med, 1990;35:1045-50.
91. Druckmann R, Druckmann MA, Progesterone and the immunology of pregnancy, J Steroid Biochem Mol Biol, 2005;97:389-96
92. Hardy DB, Janowski BA, Corey DR, Mendelson CR, Progesterone receptor plays a major antiinflammatory role in human myometrial cells by antagonism of nuclear factorkappaB activation of cyclooxygenase 2 expression, Mol Endocrinol, 2006;20:2724-33
93. Allport VC, Pieber D, Slater DM, et al., Human labour is associated with nuclear factor-kappaB activity which mediates cyclo-oxygenase-2 expression and is involved with the 'functional progesterone withdrawal', Mol Hum Reprod, 2001;7:581-6.
94. Miller L, Hunt JS, Regulation of TNF-alpha production in activated mouse macrophages by progesterone, J Immunol, 1998;160:5098-104
95. Piccinni MP, Giudizi MG, Biagiotti R, et al., Progesterone favors the development of human T helper cells producing Th2-type cytokines and promotes both IL-4 production and membrane CD30 expression in established Th1 cell clones, J Immunol, 1995;155:128-33.
96. Elovitz M, Wang Z, Medroxyprogesterone acetate, but not progesterone, protects against inflammation-induced parturition and intrauterine fetal demise, Am J Obstet Gynecol, 2004;190:693-701
97. Chandiramani M, Seed PT, Ekbote UV, et al., CLIC: a longitudinal study of inflammatory markers and cervical change in women at risk of spontaneous preterm labour, Reprod Sci, 2010;17(Suppl. 3):156A.
98. Norman JE, Yuan M, Anderson L, et al., Effect of prolonged in vivo administration of progesterone in pregnancy on myometrial gene expression, peripheral blood leukocyte activation, and circulating steroid hormone levels, Reprod Sci, 2011;18:435-46.
99. Hassan SS, Romero R, Berry SM, et al., Patients with an ultrasonographic cervical length < or =15 mm have nearly a 50% risk of early spontaneous preterm delivery, Am J Obstet Gynecol, 2000;182:1458-67. 100.
100. Berghella V, Rafael TJ, Szychowski JM, et al., Cerclage for short cervix on ultrasonography in women with singleton gestations and previous preterm birth: a meta-analysis, Obstet Gynecol, 2011;117:663-71. 101.
101. Groom KM, Shennan AH, Bennett PR, Ultrasound-indicated cervical cerclage: outcome depends on preoperative cervical length and presence of visible membranes at time of cerclage, Am J Obstet Gynecol, 2002;187:445-9. 102.
102. Hassan S, Romero R, Hendler I, et al., A sonographic short cervix as the only clinical manifestation of intra-amniotic infection, J Perinat Med, 2006;34:13-9. 103.
103. Romero R, Gonzalez R, Sepulveda W, et al., Infection and labor. VIII. Microbial invasion of the amniotic cavity in patients with suspected cervical incompetence: prevalence and clinical significance, Am J Obstet Gynecol, 1992;167:1086-91. 104.
104. Vaisbuch E, Hassan SS, Mazaki-Tovi S, et al., Patients with an asymptomatic short cervix (
105. Sakai M, Shiozaki A, Tabata M, et al., Evaluation of effectiveness of prophylactic cerclage of a short cervix according to interleukin-8 in cervical mucus, Am J Obstet Gynecol, 2006;194:14-9. 106.
106. King J, Flenady V, Cole S, Thornton S, Cyclo-oxygenase (COX) inhibitors for treating preterm labour, Cochrane Database Syst Rev, 2005(2):CD001992. 107.
107. Loudon JA, Groom KM, Bennett PR, Prostaglandin inhibitors in preterm labour, Best Pract Res Clin Obstet Gynaecol, 2003; 17:731-44. 108.
108. Sawdy RJ, Sullivan MH, Bennett PR, The effects of non-steroidal anti-inflammatory compounds on human myometrial contractility, Eur J Obstet Gynecol Reprod Biol, 2003;109:33-40. 109.
109. Yin MJ, Yamamoto Y, Gaynor RB, The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinasebeta, Nature, 1998;396:77-80. 110.
110. Groom KM, Shennan AH, Jones BA, et al., TOCOX - a randomised, double-blind, placebo-controlled trial of rofecoxib (a COX-2-specific prostaglandin inhibitor) for the prevention of preterm delivery in women at high risk, BJOG, 2005;112:725-30. 111.
111. Carey JC, Klebanoff MA, Hauth JC, et al., Metronidazole to prevent preterm delivery in pregnant women with asymptomatic bacterial vaginosis. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units, N Engl J Med, 2000;342:534-40. 112.
112. Shennan A, Crawshaw S, Briley A, et al., A randomised controlled trial of metronidazole for the prevention of preterm birth in women positive for cervicovaginal fetal fibronectin: the PREMET Study, BJOG, 2006;113:65-74. 113.
113. Kenyon S, Pike K, Jones DR, et al., Childhood outcomes after prescription of antibiotics to pregnant women with spontaneous preterm labour: 7-year follow-up of the ORACLE II trial, Lancet, 2008;372:1319-27. 114.
114. Pirianov G, Waddington SN, Lindstrom TM, et al., The cyclopentenone 15-deoxy-delta 12,14-prostaglandin J(2) delays lipopolysaccharide-induced preterm delivery and reduces mortality in the newborn mouse, Endocrinology, 2009;150:699-706.